Advanced Bioscience Laboratories, Inc. Federal Contracts
Advanced Bioscience Laboratories, Inc. of Potomac, Maryland won $13.4 million in federal contracts from Oct 18, 2025 to Oct 18, 2026, mostly from the National Institutes of Health, for research and development in the physical, engineering, and life sciences (except nanotechnology and biotechnology) and computer systems design services. It is part of Compagnie Merieux Alliance.
| Unique Entity ID (UEI) | MK4QC9EKZXG8 |
|---|---|
| Location | Potomac, Maryland |
| Parent company | Compagnie Merieux Alliance |
| Business types | Small business |
Agencies that paid Advanced Bioscience Laboratories, Inc.
- National Institutes of Health: $13.4 million
What Advanced Bioscience Laboratories, Inc. sells to the government
- Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) (NAICS 541715): $9.8 million
- Computer Systems Design Services (NAICS 541512): $2.2 million
- Research and Development in Biotechnology (except Nanobiotechnology) (NAICS 541714): $1.5 million
- Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology) (NAICS 541712): $21,050
- Medicinal and Botanical Manufacturing (NAICS 325411): $-149,724
Advanced Bioscience Laboratories, Inc.'s largest contracts with recent activity
- $17.2 million, National Institutes of Health, from Jun 10, 2017: The task order is to support cgmp manufacturing of the pgt121.414.ls monoclonal antibody (pgt121.414.ls mab) drug substance from an established manufacturing process, complete the fill finish of the… (75N93023F00001)
- $12.9 million, National Institutes of Health, from Aug 9, 2018: Niaid preclinical development support- cgmp manufacturing of pgt121 and pgdm1400 antibodies (75N93018F00009)
- $11.5 million, National Institutes of Health, from Sep 30, 2022: Cgmp manufacture of vhca8* for the treatment of pain (75N95024F00002)
- $7.2 million, National Institutes of Health, from Sep 17, 2015: Niaid preclinical development support - production of ecd-ig protein (HHSN27200029)
- $6.1 million, National Institutes of Health, from Jun 29, 2017: Nonhuman primate purchase and holding (HHSN27200007)
- $3.8 million, National Institutes of Health, from Jul 1, 2024: Expertise in using bitter taste receptor blockers to improve the palatability of pediatric medicines: blocker discovery (75N93024F00001)
Amounts are each contract's total value; the contracts had spending in the last 12 months.
Open bids in Advanced Bioscience Laboratories, Inc.'s trades
354 open federal notices today are in the trades Advanced Bioscience Laboratories, Inc. sells most. The newest:
Award figures: contract obligations reported to USAspending.gov, read Oct 18, 2026.
Questions about Advanced Bioscience Laboratories, Inc.
How much does Advanced Bioscience Laboratories, Inc. get in federal contracts?
$13.4 million in contract obligations from Oct 18, 2025 to Oct 18, 2026, the most from the National Institutes of Health ($13.4 million).
What does Advanced Bioscience Laboratories, Inc. sell to the federal government?
research and development in the physical, engineering, and life sciences (except nanotechnology and biotechnology), computer systems design services and research and development in biotechnology (except nanobiotechnology).